Brief: Lipum Strengthens Protection Of Drug Candidate Sol-116 Through Patent Application For Inflammation-Driven Cancer

Lipum AB (publ)

02/04/2024 08:13

April 2 (Reuters) - Lipum AB (publ)  LIPUM.ST :
    * STRENGTHENS ITS PROTECTION OF THE DRUG CANDIDATE SOL-116
THROUGH
A PATENT APPLICATION FOR INFLAMMATION-DRIVEN CANCER

Source text for Eikon:  ID:nMFN20vNXN 
Further company coverage:  LIPUM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))